112
Participants
Start Date
September 12, 2018
Primary Completion Date
March 26, 2019
Study Completion Date
March 26, 2019
Idelalisib
Tablets were administered in accordance with the marketing authorization.
Rituximab
Tablets were administered in accordance with the marketing authorization.
St James Hospital, Dublin
NHS Grampian, Aberdeen
University Hospital of Wales, Cardiff
Cheltenham General Hospital, Cheltenham
London Northwest University NHS Trust, Eastcote
Medway Maritime Hospital, Gillingham
Queen Alexandra Hospital, Harrow
King's College Hospital NHS Foundation Trust, London
Milton Keynes University Hospital, Milton Keynes
Oxford University Hospitals NHS Trust, Oxford
Whiston Hospital - St Helens And Knowsley Teaching Hospitals NHS Trust, Prescot
Southend University Hospital NHS Foundation Trust, Southend-on-Sea
Royal Marsden Hospital, Sutton
Singleton Hospital, Swansea
Royal Cornwall Hospital, Truro
Worcestershire Royal Hospital, Worcester
Lead Sponsor
Gilead Sciences
INDUSTRY